[Federal Register Volume 70, Number 213 (Friday, November 4, 2005)]
[Notices]
[Pages 67179-67180]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-22013]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Advisory Committee on Special Studies Relating to the Possible 
Long-Term Health Effects of Phenoxy Herbicides and Contaminants (Ranch 
Hand Advisory Committee); Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Advisory Committee on Special Studies Relating 
to the Possible Long-Term Health Effects of Phenoxy Herbicides and 
Contaminants (Ranch Hand Advisory Committee).
    General Function of the Committee: To advise the Secretary of 
Health and Human Services (the Secretary) and the Assistant Secretary 
for Health concerning its oversight of the conduct of the Ranch Hand 
study by the U.S. Air Force and provide scientific oversight of the 
Department of Veterans Affairs Army Chemical Corps Vietnam Veterans 
Health Study, and other studies in which the Secretary or the Assistant 
Secretary for Health believes involvement by the committee is 
desirable.
    Date and Time: The meeting will be held on November 18, 2005, from 
8:30 a.m. to 4 p.m.
    Location: Food and Drug Administration, 5630 Fishers Lane, rm. 
1066, Rockville, MD 20857.
    Contact Person: Leonard Schechtman, National Center for 
Toxicological Research (HFT-10), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-827-6696, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 3014512560. Please call the Information Line 
for up-to-date information on this meeting.
    Agenda: The committee will discuss the following items: (1) Updates 
and interactions with the Institute of Medicine's Air Force Health 
Study (AFHS) Disposition Study Committee; (2) AFHS closure 
preparations; (3) updates from the Air Force on the AFHS history, 
program management, and the Comprehensive Study Report; (4)

[[Page 67180]]

update from the Air Force on the 2002 AFHS Physical Examination Report; 
and (5) discussion of AFHS fiscal year 2006 activities.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by November 10, 
2005. Oral presentations from the public will be scheduled on November 
18, 2005, between approximately 11:15 a.m. to 12:15 p.m. Time allotted 
for each presentation may be limited. Those desiring to make formal 
oral presentations should likewise notify the contact person before 
November 10, 2005, and submit a brief statement of the general nature 
of the evidence or arguments they wish to present, the names and 
addresses of proposed participants, and an indication of the 
approximate time requested to make their presentation.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Leonard Schechtman 
at least 7 days in advance of the meeting.

    Dated: October 28, 2005.
Jason Brodsky,
Acting Associate Commissioner for External Relations.
[FR Doc. 05-22013 Filed 11-3-05; 8:45 am]
BILLING CODE 4160-01-S